SWM
NBRV

SeaCrest Wealth Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

SeaCrest Wealth Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-124
Closed -$21K – 624
2020
Q2 		$21K Hold
124
– – ﹤0.01% 550
2020
Q1 		$18K Buy
+124
New +$37.9K ﹤0.01% 508

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return

SeaCrest Wealth Management's NBRV Position: Q3 2020 in Review

SeaCrest Wealth Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2020, closing a stake of 124 shares — an estimated $21K sold.

SeaCrest Wealth Management first reported a position in NBRV in Q1 2020 and held it in 2 quarters. The position peaked at $21K in Q2 2020. 49 funds tracked by Wall St. Rank hold NBRV as of Q3 2020.

  • SeaCrest Wealth Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2020 after selling out during the quarter.
  • SeaCrest Wealth Management sold 124 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2020, an estimated $21K.
  • SeaCrest Wealth Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q1 2020 and held it in 2 quarters.
  • SeaCrest Wealth Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $21K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2020.

Based on SeaCrest Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.